Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Daniel Amoussou-Guenou

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Diabetes & Metabolic Syndrome|March 11, 2016
The normal-weight type 2 diabetes phenotype revisitedMichel P Hermans, K Daniel Amoussou-Guenou, Evariste Bouenizabila, et al.
Diabetes & Metabolic Syndrome|September 18, 2022
Fatty liver and atherogenic dyslipidemia have opposite effects on diabetic micro- and macrovascular diseaseMichel P Hermans, Evariste Bouenizabila, K Daniel Amoussou-Guenou, et al.
Diabetes & Metabolic Syndrome|September 26, 2016
Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and β-cell function in men with T2DMMichel P Hermans, K Daniel Amoussou-Guenou, Evariste Bouenizabila, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Diabetes & Metabolic Syndrome|March 11, 2016
The normal-weight type 2 diabetes phenotype revisitedMichel P Hermans, K Daniel Amoussou-Guenou, Evariste Bouenizabila, et al.
Diabetes & Metabolic Syndrome|September 18, 2022
Fatty liver and atherogenic dyslipidemia have opposite effects on diabetic micro- and macrovascular diseaseMichel P Hermans, Evariste Bouenizabila, K Daniel Amoussou-Guenou, et al.
Diabetes & Metabolic Syndrome|September 26, 2016
Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and β-cell function in men with T2DMMichel P Hermans, K Daniel Amoussou-Guenou, Evariste Bouenizabila, et al.
Pageof 1